FIELD: veterinary medicine.
SUBSTANCE: group of inventions relates to use of a vaccine containing a non-living Lawsonia intracellularis antigen and a pharmaceutically acceptable carrier and to a method for reducing the negative effect on the average daily weight gain in swine (ADWG), associated with subclinical Lawsonia intracellularis infection. Vaccine is used to reduce negative effect on average daily weight gain in swine (ADWG), associated with subclinical Lawsonia intracellularis infection, by systemic administration of vaccine to a pig.
EFFECT: group of inventions enables treating a subclinical Lawsonia intracellularis infection.
10 cl, 5 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| VACCINE FOR USE AGAINST SUBCLINICAL INFECTION LAWSONIA IN PIGS | 2016 |
|
RU2709197C2 |
| VACCINE AGAINST LAWSONIA INTRACELLULARIS | 2009 |
|
RU2523561C2 |
| Lawsonia-BASED VACCINE AND METHODS OF ITS APPLICATION | 2006 |
|
RU2420310C2 |
| SWINE VACCINE AGAINST PRRS AND LAWSONIA INTRACELLULARIS | 2014 |
|
RU2655615C1 |
| VACCINE FOR PROTECTION AGAINST LAWSONIAINTRACELLULARIS, MYCOPLASMA HYOPNEUMONIAE AND PORCINE CIRCOVIRUS | 2009 |
|
RU2496520C2 |
| PORCINE CIRCOVIRUS TYPE 2 VACCINE | 2014 |
|
RU2712155C2 |
| VACCINE AGAINST LAWSONIA INTRACELLULARIS AND PORCINE CIRCOVIRUS 2 | 2014 |
|
RU2672251C1 |
| VACCINES CONTAINING PORCINE PATHOGENS FOR ASSOCIATED UNMIXED USE | 2018 |
|
RU2756767C2 |
| Lawsonia intracellulars OF EUROPEAN ORIGIN AND BASED VACCINES, DIAGNOSTIC AGENTS AND METHODS OF APPLICATION THEREOF | 2004 |
|
RU2420570C2 |
| COMBINED PORCINE VACCINE | 2017 |
|
RU2761453C2 |
